For: | Nakashima S, Ota S, Arai S, Yoshino K, Inao M, Ishikawa K, Nakayama N, Imai Y, Nagoshi S, Mochida S. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin. World J Gastroenterol 2009; 15(6): 727-731 [PMID: 19222098 DOI: 10.3748/wjg.15.727] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i6/727.htm |
Number | Citing Articles |
1 |
Siew C Ng, Francis KL Chan. NSAID-induced gastrointestinal and cardiovascular injury. Current Opinion in Gastroenterology 2010; 26(6): 611 doi: 10.1097/MOG.0b013e32833e91eb
|
2 |
Chen Mo, Gang Sun, Yan-Zhi Wang, Ming-Liang Lu, Yun-Sheng Yang, John Green. PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis. PLOS ONE 2015; 10(7): e0131558 doi: 10.1371/journal.pone.0131558
|
3 |
Hironori NAKAMURA, Haruko YOKOYAMA, Takehiro YAGUCHI, Yuji SUZUKI, Kentaro TOKUOKA, Masayuki WATANABE, Yasuhisa KITAGAWA, Yasuhiko YAMADA. Investigation into the Effect of Gastric Secretion Inhibitor for the Prevention of Upper Gastrointestinal Lesions Associated with Low-dose Aspirin. YAKUGAKU ZASSHI 2011; 131(3): 445 doi: 10.1248/yakushi.131.445
|
4 |
Sang Gyun Kim, Nayoung Kim, Sung Kwan Shin, In Kyung Sung, Su Jin Hong, Hyo-Jin Park. Efficacy of Albis for the Prevention of Gastric Mucosal Injury Concomitant with the Use of Low-Dose Aspirin: A Prospective, Randomized, Placebo-Controlled Study. Clinical Endoscopy 2017; 50(2): 179 doi: 10.5946/ce.2016.031
|
5 |
Isamu Tamura, Tsuyoshi Fujita, Hidetaka Tsumura, Yoshinori Morita, Masaru Yoshida, Takashi Toyonaga, Seiichi Hirano, Hideto Inokuchi, Hiromu Kutsumi, Takeshi Azuma. Low-Dose Aspirin-Induced Gastroduodenal Mucosal Injury in Japanese Patients with Arteriosclerotic Disease. Internal Medicine 2010; 49(23): 2537 doi: 10.2169/internalmedicine.49.3824
|
6 |
Paola Patrignani, Stefania Tacconelli, Annalisa Bruno, Carlos Sostres, Angel Lanas. Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert Review of Clinical Pharmacology 2011; 4(5): 605 doi: 10.1586/ecp.11.36
|
7 |
Ryan Wilson, Jawahar Gazzala, Jeff House. Aspirin in Primary and Secondary Prevention in Elderly Adults Revisited. Southern Medical Journal 2012; 105(2): 82 doi: 10.1097/SMJ.0b013e3182426eef
|
8 |
Chen Mo, Gang Sun, Ming-Liang Lu, Li Zhang, Yan-Zhi Wang, Xi Sun, Yun-Sheng Yang. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World Journal of Gastroenterology 2015; 21(17): 5382-5392 doi: 10.3748/wjg.v21.i17.5382
|
9 |
Carlos Sostres, Angel Lanas. Should Prophylactic Low-dose Aspirin Therapy be Continued in Peptic Ulcer Bleeding?. Drugs 2011; 71(1): 1 doi: 10.2165/11585320-000000000-00000
|
10 |
Masafumi Nishino, Mitsushige Sugimoto, Chise Kodaira, Mihoko Yamade, Takahiro Uotani, Naohito Shirai, Mutsuhiro Ikuma, Tatsuo Tanaka, Haruhiko Sugimura, Akira Hishida, Takahisa Furuta. Preventive Effects of Lansoprazole and Famotidine on Gastric Mucosal Injury Induced by Low‐Dose Aspirin in Helicobacter pylori—Negative Healthy Volunteers. The Journal of Clinical Pharmacology 2011; 51(7): 1079 doi: 10.1177/0091270010376194
|
11 |
Minoru Tomizawa, Fuminobu Shinozaki, Rumiko Hasegawa, Yoshinori Shirai, Yasufumi Motoyoshi, Takao Sugiyama, Shigenori Yamamoto, Naoki Ishige. Immunosuppressive agents are associated with peptic ulcer bleeding. Experimental and Therapeutic Medicine 2017; 13(5): 1927 doi: 10.3892/etm.2017.4214
|